Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

This CD contains the following articles listed by volume, issue and page number:

STABILITIES, COMPATIBILITIES RELATED ARTICLES
Title (Click for Details)	Vol/Issue	Page
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3	Vol. 15 No. 6	488
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags	Vol. 15 No. 6	515
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions	Vol. 15 No. 5	428
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations	Vol. 15 No. 5	435
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate	Vol. 15 No. 4	344
Stability of Ertapenem in an Elastomeric Infusion Device	Vol. 15 No. 3	252
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles	Vol. 15 No. 3	255
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations	Vol. 15 No. 3	259
Drug Compatibility and Stability in Dextrose vs Saline	Vol. 15 No. 3	190
Basics of Compounding: Basics of Compounding with Complex Organic Molecules	Vol. 15 No. 3	234
Basics of Compounding: Basics of Compounding with Inorganic Salts	Vol. 15 No. 2	146
Nifedpine in Compounded Oral and Topical Preparations	Vol. 15 No. 2	166
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes	Vol. 15 No. 2	170
Maillard Reactions in Pharmaceutical Formulations and Human Health	Vol. 15 No. 1	32
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs	Vol. 15 No. 1	74
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form	Vol. 15 No. 1	78
Stability of Venlafaxine Immediate-Release Suspensions	Vol. 15 No. 1	81
PreScription: Compounding with Manufactured Products	Vol. 14 No. 6	448
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date	Vol. 14 No. 6	522
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study	Vol. 14 No. 5	430
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device	Vol. 14 No. 5	436
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents	Vol. 14 No. 4	284
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping	Vol. 14 No. 4	342
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin	Vol. 14 No. 4	346
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations	Vol. 14 No. 3	232
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration	Vol. 14 No. 3	250
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules	Vol. 14 No. 2	118
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector	Vol. 14 No. 2	160
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle	Vol. 14 No. 1	76
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam	Vol. 14 No. 1	78
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)	Vol. 14 No. 1	82
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding	Vol. 13 No. 6	525
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes	Vol. 13 No. 6	564
Chemical Stability of Scopolamine Hydrobromide Nasal Solution	Vol. 13 No. 5	438
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms	Vol. 13 No. 5	445
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding	Vol. 13 No. 3	250
Stability of Pergolide Mesylate Oral Liquid at Room Temperature	Vol. 13 No. 3	254
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers	Vol. 13 No. 2	162
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions	Vol. 13 No. 2	166
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule	Vol. 13 No. 2	170
Identifying the Criteria of a Valid Stability Study	Vol. 13 No. 1	32
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration	Vol. 13 No. 1	78
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution	Vol. 12 No. 5	456
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration	Vol. 12 No. 5	460
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration	Vol. 12 No. 5	463
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations	Vol. 12 No. 6	524
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties	Vol. 12 No. 6	550
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration	Vol. 12 No. 6	553
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System	Vol. 12 No. 6	558
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating	Vol. 12 No. 4	344
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms	Vol. 12 No. 4	372
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration	Vol. 12 No. 4	368
Chemical Stability of Naltrexone Hydrochloride Injection	Vol. 12 No. 3	274
Dilution and Compounding of Ziconotide for Intrathecal Administration	Vol. 12 No. 3	200
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration	Vol. 12 No. 3	276
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!	Vol. 12 No. 2	130
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration	Vol. 12 No. 2	156
Chemical Stability of Tramadol Hydrochloride Injection	Vol. 12 No. 2	161
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting	Vol. 12 No. 2	163
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration	Vol. 12 No. 2	170
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method	Vol. 12 No. 1	50
Room Temperature Stability of Injectable Succinylcholine Dichloride	Vol. 12 No. 1	83
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration	Vol. 11 No. 6	520
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion	Vol. 11 No. 5	426
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form	Vol. 11 No. 4	347
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents	Vol. 11 No. 3	259
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations	Vol. 11 No. 2	164
Pediatric Oral Formulations: A Continual Challenge	Vol. 11 No. 1	17
Sevelamer Suspension in Children with End-Stage Renal Disease	Vol. 11 No. 1	20
Chemical Stability of Desonide in Ear Drops	Vol. 11 No. 1	79
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration	Vol. 11 No. 1	82
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions	Vol. 10 No. 5	396
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free	Vol. 10 No. 4	318
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729>	Vol. 10 No. 4	309
Stability of Memantine in an Extemporaneously Prepared Oral Liquid	Vol. 10 No. 4	316
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration	Vol. 10 No. 3	230
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration	Vol. 10 No. 3	234
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together	Vol. 10 No. 3	237
Chemical Stability of Diclofenac Sodium Injection	Vol. 10 No. 2	154
Extended Stability of Oxytocin in Common Infusion Solutions	Vol. 10 No. 2	156
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management	Vol. 10 No. 1	69
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds	Vol. 10 No. 1	74
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags	Vol. 9 No. 6	482
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms	Vol. 9 No. 6	484
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration	Vol. 9 No. 5	396
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion	Vol. 9 No. 5	399
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations	Vol. 9 No. 5	402
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration	Vol. 9 No. 4	320
Stability of Nebulizer Admixtures	Vol. 9 No. 4	323
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration	Vol. 9 No. 3	235
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration	Vol. 9 No. 3	238
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form	Vol. 9 No. 2	165
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature	Vol. 9 No. 1	72
Stability of an Extemporaneously Compounded Propylthiouracil Suspension	Vol. 9 No. 1	82
Stability of Extemporaneous Oral Ribavirin Liquid Preparation	Vol. 8 No. 6	486
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink	Vol. 8 No. 6	489
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension	Vol. 8 No. 6	492
Book and Literature Reviews	Vol. 8 No. 5	324
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate	Vol. 8 No. 5	398
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags	Vol. 8 No. 5	404
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.	Vol. 8 No. 3	228
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.	Vol. 8 No. 3	231
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours.	Vol. 8 No. 3	236
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution	Vol. 8 No. 2	147
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion	Vol. 8 No. 2	153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags	Vol. 8 No. 2	156
Vancomycin HCl and Heparin Sodium Injection	Vol. 8 No. 1	60
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours	Vol. 8 No. 1	73
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder	Vol. 7 No. 5	386
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride	Vol. 7 No. 5	389
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets	Vol. 7 No. 3	233
Stability of Clindamycin Phosphate in AutoDose Infusion System Bags	Vol. 7 No. 2	149
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 7 No. 2	152
Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis	Vol. 7 No. 2	155
Stability of Glycopyrrolate Injection at Ambient Temperature and 4°C in Polypropylene Syringes	Vol. 7 No. 1	65
Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes	Vol. 7 No. 1	68
Chemical Stability of Furosemide in Minibags and Polypropylene Syringes	Vol. 6 No. 6	468
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes	Vol. 6 No. 6	475
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes	Vol. 6 No. 6	471
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes	Vol. 6 No. 5	388
Effect of Freezing, Long-Term Storage, and Microwave Thawing on the Stability of Cefepime in 5% Dextrose Infusion Polyvinyl Chloride Bags	Vol. 6 No. 5	391
Chemical Stability of Dexamethasone Sodium Phosphate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes	Vol. 6 No. 5	395
Stability of Tubocurarine Chloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes	Vol. 6 No. 4	308
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs	Vol. 6 No. 4	311
Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storage in 1-mL Tuberculin Polypropylene Syringes for Pediatric Use	Vol. 6 No. 4	316
pH and Osmolarity, A Review of	Vol. 6 No. 3	216
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags	Vol. 6 No. 3	226
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs	Vol. 6 No. 3	230
Stability of Cefotaxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 6 No. 3	234
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags	Vol. 6 No. 2	152
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules	Vol. 6 No. 2	155
Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes	Vol. 6 No. 1	62
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes	Vol. 6 No. 1	66
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes	Vol. 6 No. 1	70
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes	Vol. 6 No. 1	74
Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion	Vol. 5 No. 6	456
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets	Vol. 5 No. 6	480
Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes	Vol. 5 No. 6	482
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes	Vol. 5 No. 5	394
Assessment of the Stability of Teicoplanin in Intravenous Infusions	Vol. 5 No. 5	397
Analytical Testing Facilities and Products	Vol. 5 No. 4	284
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration	Vol. 5 No. 4	314
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions	Vol. 5 No. 4	323
Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study	Vol. 5 No. 3	195
Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 3	230
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid	Vol. 5 No. 3	232
Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes	Vol. 5 No. 2	148
Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 2	151
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate	Vol. 5 No. 2	153
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients	Vol. 5 No. 1	9
Sterile-Product Preparations: Mix or Buy?	Vol. 5 No. 1	59
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs	Vol. 5 No. 1	69
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 1	73
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 5 No. 1	75
Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate	Vol. 4 No .6	476
Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 4 No .6	480
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes	Vol. 4 No .6	482
Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 4 No. 5	396
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets	Vol. 4 No. 5	398
Short Communication: Compounding for Implantable Pumps	Vol. 4 No. 4	280
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection	Vol. 4 No. 4	296
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection	Vol. 4 No. 4	298
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs	Vol. 4 No. 4	318
Three Drug Stability Lives	Vol. 4 No. 3	190
Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs	Vol. 4 No. 3	225
Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation	Vol. 4 No. 3	229
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography	Vol. 4 No. 3	233
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution	Vol. 4 No. 2	146
Effect of Some Antioxidants on the Color Change of White Lotion	Vol. 4 No. 2	154
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration	Vol. 4 No. 2	150
Compounding Intrathecal Medications	Vol. 4 No. 1	24
Particulates in Parenterals	Vol. 4 No. 1	43
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection	Vol. 4 No. 1	66
Naratriptan HCl in Extemporaneously Compounded Oral Suspensions	Vol. 4 No. 1	69
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids	Vol. 4 No. 1	72
Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure	Vol. 3 No. 6	488
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C	Vol. 3 No. 5	412
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II	Vol. 3 No. 5	415
Extemporaneous Formulations in Pediatric Patients	Vol. 3 No. 4	274
Parenteral Admixture with Y-Site Administration	Vol. 3 No. 4	303
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution	Vol. 3 No. 4	306
Veterinary Flavor Suggestions	Vol. 3 No. 3	186
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride	Vol. 3 No. 3	235
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration	Vol. 3 No. 3	241
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography	Vol. 3 No. 3	239
Analysis of Extemporaneous Alprostadil Formulations	Vol. 3 No. 2	148
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags	Vol. 3 No. 2	156
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks	Vol. 3 No. 1	56
Stability of Four Commercial Products Delivered by Mail Order	Vol. 3 No. 1	59
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital	Vol. 3 No. 1	64
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature	Vol. 3 No. 1	67
Chemical Stability of Meperidine Hydrochloride in Polypropylene Syringes	Vol. 2 No. 6	463
Stability of Sufentanil in a Syringe Pump Under Simulated Epidural Infusion	Vol. 2 No. 6	466
Stability of Albuterol in Continuous Nebulization	Vol. 2 No. 5	394
The Stability of Amphotericin B in a Mixture of Fungizone and Optimoist	Vol. 2 No. 4	311
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form	Vol. 2 No. 4	314
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration	Vol. 2 No. 4	318
Stability of Lorazepam in 5% Dextrose Injection	Vol. 2 No. 4	322
Paclitaxel Compatibility with IV Express Filter Unit	Vol. 2 No. 3	243
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL	Vol. 2 No. 3	246
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection	Vol. 2 No. 2	168
Stability of Indomethacin in 0.9% Sodium Chloride Injection	Vol. 2 No. 2	170
The pH Value of Urea Solutions in Purified Water	Vol. 2 No. 1	76
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion	Vol. 2 No. 1	79
Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base	Vol. 2 No. 1	89
Basic Statistical Concepts for Evaluating Pharmaceutical Compounding Literature: Part 1.Statistics for Continuous Data and Stability Studies	Vol. 1 No. 6	395
Stability of Two Concentrations of Heparin Sodium Prefilled in CADD-Micro Pump Syringes	Vol. 1 No. 6	433
Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection	Vol. 1 No. 6	435
Short-Term Stability of Atenolol in Oral Liquid Formulations	Vol. 1 No. 6	437
Stability of Clonazepam Suspension in HSC Vehicle	Vol. 1 No. 6	440
Drug Stability and Compatibility: Special Considerations for Home Health Care	Vol. 1 No. 5	301
Chemical Stability of Amiodarone Hydrochloride in Intravenous Fluids	Vol. 1 No. 5	347
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms	Vol. 1 No. 5	349
The Stability of Lisinopril as an Extemporaneous Syrup	Vol. 1 No. 5	352
Compatibility of Vancomycin Hydrochloride and Famotidine in 5% Dextrose Injection	Vol. 1 No. 5	354
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions	Vol. 1 No. 5	356
Stability of Ceftriaxone Sodium When Mixed with Metronidazole Injection	Vol. 1 No. 4	280
Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes	Vol. 1 No. 4	282
Parenteral Admixture Incompatibilities:An Introduction	Vol. 1 No. 3	165
Physical Stability of Urea Topical Formulations	Vol. 1 No. 3	168
The Formulation Development and Stability of Spironolactone Suspension	Vol. 1 No. 3	195
The Formulation Development and Stability of Metronidazole Suspension	Vol. 1 No. 3	200
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections	Vol. 1 No. 3	206
Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection	Vol. 1 No. 3	208
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration	Vol. 1 No. 2	118
The Compatibility of Common Respiratory Therapy Drug Combinations	Vol. 1 No. 2	121
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs	Vol. 1 No. 2	123
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture	Vol. 1 No. 2	125
Stability of Allopurinol Suspension Compounded from Tablets	Vol. 1 No. 2	128
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection	Vol. 1 No. 2	132
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion	Vol. 1 No. 1	49